Rajbir Kaur
Impact in
- Family Practice top 1%
- Medication Adherence and Compliance
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Natural product bioactivities and synthesis 5
- Phytochemical compounds biological activities 4
- Bone Metabolism and Diseases 2
-
- Phytochemistry and Bioactivity Studies 4
- Co-authors
- Diana M Sobieraj (4 shared papers)Matthew Roberts (3 shared papers)Craig I Coleman (3 shared papers)Soyon Lee (3 shared papers)Saroj Arora (9 shared papers)Brendan Limone (1 shared paper)Bikram Singh (4 shared papers)Prabhdeep Singh (4 shared papers)
- Journals
- Current Medical Research and Opinion (2 papers)Circulation Heart Failure (1 paper)Medicinal Chemistry Research (1 paper)Molecular Carcinogenesis (1 paper)Bioresource Technology (1 paper)
- Partner nations
- IndiaUnited StatesGermany
In The Last Decade
Rajbir Kaur
30 papers receiving 871 citations
Rajbir Kaur's Hit Papers
Peers
Comparison fields: 5 of 128
- Family Practice 110
- Geriatrics and Gerontology 33
- Biochemistry 56
- Internal Medicine 29
- Pharmacology 50
Countries citing papers authored by Rajbir Kaur
This map shows the geographic impact of Rajbir Kaur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajbir Kaur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajbir Kaur more than expected).
Fields of papers citing papers by Rajbir Kaur
This network shows the impact of papers produced by Rajbir Kaur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajbir Kaur. The network helps show where Rajbir Kaur may publish in the future.
Co-authors
The 25 scholars most cited alongside Rajbir Kaur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dosing Frequency and Medication Adherence in Chronic Disease Hit paper breakdown → | 2012 | 334 |
| 2 | 2012 | 105 | |
| 3 | 2008 | 80 | |
| 4 | 2015 | 56 | |
| 5 | 2020 | 37 | |
| 6 | 2018 | 28 | |
| 7 | 2011 | 26 | |
| 8 | 2009 | 22 | |
| 9 | 2011 | 21 | |
| 10 | 2021 | 21 | |
| 11 | 2014 | 20 | |
| 12 | 2021 | 19 | |
| 13 | 2021 | 15 | |
| 14 | 2010 | 14 | |
| 15 | Amelioration of oxidative damage by Methyl gallate in different in vitro models | 2011 | 14 |
| 16 | 2008 | 13 | |
| 17 | 2021 | 12 | |
| 18 | 2019 | 11 | |
| 19 | 2015 | 11 | |
| 20 | 2014 | 10 |
About Rajbir Kaur
Rajbir Kaur is a scholar working on Molecular Biology, Pharmacology, Pharmacology, Radiology, Nuclear Medicine and Imaging and Family Practice, having authored 32 papers that have together received 904 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (5 papers), Phytochemistry and Bioactivity Studies (4 papers), Phytochemical compounds biological activities (4 papers), COVID-19 diagnosis using AI (4 papers), Medication Adherence and Compliance (3 papers), Phytochemicals and Antioxidant Activities (3 papers), Anomaly Detection Techniques and Applications (2 papers) and Bone Metabolism and Diseases (2 papers). The work is most often cited by research in Family Practice (110 citations), Geriatrics and Gerontology (33 citations), Biochemistry (56 citations), Internal Medicine (29 citations) and Pharmacology (50 citations). Rajbir Kaur has collaborated with scholars based in India, United States and Germany. Frequent co-authors include Diana M Sobieraj, Matthew Roberts, Craig I Coleman, Soyon Lee, Saroj Arora, Brendan Limone, Bikram Singh, Prabhdeep Singh, Gaurav Dhiman and Kiran Deep Singh. Their work appears in journals such as Current Medical Research and Opinion, Circulation Heart Failure, Medicinal Chemistry Research, Molecular Carcinogenesis and Bioresource Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.